Tina Corkran, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6401 Cypresswood Dr, Suite 180, Spring, TX 77379 Phone: 281-866-7080 |
News Archive
Boston Scientific Corporation today announced U.S. Food and Drug Administration approval and launch of two spinal cord stimulation (SCS) lead splitters for use with its Precision Plus™ Spinal Cord Stimulator System, the world's first rechargeable SCS device for the management of chronic pain of the trunk, back and/or limbs.
Low-back pain sufferers can seek relief from any number of health professionals, orthopedists, physical therapists and osteopaths among them.
A recent study led by researchers from the Amyloidosis Center at Boston University School of Medicine and Boston Medical Center demonstrates that diflunisal, a generic anti-inflammatory drug, successfully reduced neurological decline and preserved the quality of life in patients with familial transthyretin amyloidosis. Diflunisal is an inexpensive and safe medication marketed over the past 40 years for arthritis and pain.
At a recent event in Miami, Nobel Laureate Muhammad Yunus, the founder of the Grameen Bank, outlined his idea of creating a "social business fund" in Haiti, which would invest money in businesses that aim to address social problems in the country, the Miami Herald reports.
OrbusNeich announced today that pre-clinical data involving porcine coronary models demonstrate that the company's Combo Bio-engineered Sirolimus Eluting Stent (Combo Stent) may offer advantages to the Cypher(R) sirolimus eluting stent and the XIENCE(TM) V everolimus eluting stent.
› Verified 3 days ago